Neoadjuvant SBRT followed by evorpacept and pembrolizumab in HPV-mediated head and neck squamous cell carcinoma: Investigation of pathologic response.
Ezra E.W. Cohen, Marka R. Crittenden, Robert Saddawi‐Konefka, Kyaw Zin Thein et al.
Journal
Journal of Clinical Oncology
Topics
Head and Neck Cancer Studies
article
Neoadjuvant SBRT followed by evorpacept and pembrolizumab in HPV-mediated head and neck squamous cell carcinoma: Investigation of pathologic response.
Ezra E.W. Cohen, Marka R. Crittenden, Robert Saddawi‐Konefka, Kyaw Zin Thein, Ryan J. Li, Joseph A. Califano, R. Bryan Bell, Thomas Duhen, Andrew B. Sharabi, Kristina H. Young, Rom S. Leidner, Karen Messer, Тимур Митин, Brian Piening, Xinlian Zhang, Liza Blumenfeld, Steven K. Seung
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(16_suppl)
Institutions
Oregon Health & Science University (US), UC San Diego Health System (US), Providence Portland Medical Center (US), University of California San Diego (US), Oregon Clinic (US), Tempus Labs (United States) (US)